Form 4: Aytu Biopharma Executive Receives Stock Grant
Insider Transaction (Form 4)
Greg Pyszczymuka, Chief Commercial Officer of Aytu Biopharma, Inc, received 20,000 shares of common stock on July 28, 2026.
Summary
- Grant/award: acquired 20,000 Common Stock on July 28, 2026; holds 56,102 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Greg Pyszczymuka — Officer (Chief Commercial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-28 | Grant/award | Common Stock | 20,000 | — | — | 56,102 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-28 | Grant/award (20,000 shares) |
Keywords
insider transaction, Form 4, AYTU, AYTU BIOPHARMA, INC, neutral, Greg Pyszczymuka
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.